How long can a person with mid-stage esophageal cancer typically survive?

Esophageal cancer is a malignant tumor that occurs in the epithelial cells of the esophagus, and its incidence ranks second among malignant tumors of the digestive system. In the intermediate stage of esophageal cancer, the 5-year survival rate is approximately 30%-40%, but the specific survival time varies from person to person.

1. Surgery: Radical resection can be used for early-stage patients without metastasis; 2. Radiation therapy: Using radioactive rays to kill cancer cells to achieve the purpose of treatment, suitable for patients in the middle and late stages who cannot tolerate surgery or have distant metastasis; 3. Chemotherapy: Through oral or intravenous administration of chemical drugs to kill cancer cells and achieve the purpose of treatment, often used for post-operative adjuvant treatment and palliative treatment in advanced stages.

If patients with esophageal cancer do not undergo timely and standardized treatment, the disease may progress rapidly, resulting in a shortened lifespan of about 6 months or even less. Therefore, it is recommended that patients with esophageal cancer should actively cooperate with doctors for treatment once diagnosed to extend their survival time. In daily life, attention should also be paid to maintaining a regular diet, avoiding overeating, eating more fresh fruits and vegetables, as well as high-protein foods such as eggs and milk, which are beneficial for enhancing physical fitness and improving disease resistance. At the same time, maintaining a good mindset and avoiding excessive emotional excitement, tension, or anxiety is also important. If any discomfort occurs, medical attention should be sought promptly to avoid delaying the condition.